<SEC-DOCUMENT>0000950142-24-001310.txt : 20240509
<SEC-HEADER>0000950142-24-001310.hdr.sgml : 20240509
<ACCEPTANCE-DATETIME>20240508175859
ACCESSION NUMBER:		0000950142-24-001310
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240508
FILED AS OF DATE:		20240509
DATE AS OF CHANGE:		20240508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gildan Activewear Inc.
		CENTRAL INDEX KEY:			0001061894
		STANDARD INDUSTRIAL CLASSIFICATION:	APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1229

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14830
		FILM NUMBER:		24927771

	BUSINESS ADDRESS:	
		STREET 1:		600 BOULEVARD DE MAISONNEUVE OUEST
		STREET 2:		33RD FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3A 3J2
		BUSINESS PHONE:		5147352023

	MAIL ADDRESS:	
		STREET 1:		600 BOULEVARD DE MAISONNEUVE OUEST
		STREET 2:		33RD FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3A 3J2

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILDAN ACTIVEWEAR INC
		DATE OF NAME CHANGE:	19980515
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>eh240474814_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="margin-top: 0pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Rule 13a-16 or 15d-16 of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>the Securities Exchange Act of 1934</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 8pt; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: center; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt"><B>For
    the month of:  May 2024</B></FONT></TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 48%"><FONT STYLE="font-size: 10pt"><B>Commission File Number: 1-14830</B></FONT></TD></TR>
  </TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 8pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 12pt"><B>GILDAN ACTIVEWEAR INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Translation of registrant&rsquo;s name into English)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>600 de Maisonneuve Boulevard West</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>33rd Floor</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Montr&eacute;al, Qu&eacute;bec</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Canada H3A 3J2</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Address of principal executive offices)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Form 20-F <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F <FONT STYLE="font-family: Wingdings">&#254;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="4">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt"><B>GILDAN ACTIVEWEAR INC.</B></FONT></P></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="4">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Date: May 8, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Michelle Taylor</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Michelle Taylor</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Vice-President, General Counsel and Corporate Secretary</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><B>&nbsp;</B></P>


<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; width: 9%"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 90%"><FONT STYLE="font-size: 10pt"><B>Description of Exhibit</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="eh240474814_ex9901.htm">News Release</A></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>eh240474814_ex9901.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>EXHIBIT 99.1</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Gildan
Announces a C$200 Million Private Placement Financing with CDPQ</B></FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Montr&eacute;al,
Wednesday, May 8, 2024 </B>&ndash; Gildan Activewear Inc. (GIL: TSX and NYSE) (&ldquo;Gildan&rdquo; or the &ldquo;Company&rdquo;) announced
today that it has reached an agreement to issue CAD$200 million aggregate principal amount of senior unsecured notes to Caisse de d&eacute;p&ocirc;t
et placement du Qu&eacute;bec (&ldquo;CDPQ&rdquo;) on a private placement basis. The notes will bear interest at a rate of 6.0% per year
and will mature 5 years from the issuance date. Gildan intends to use the net proceeds of the issuance to fund its common share repurchase
program and for the repayment of maturing outstanding debt.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Gildan
has agreed to maintain strong local leadership and its global headquarters in Qu&eacute;bec for a minimum of 7 years, and has committed
to becoming a Global Minimum Taxpayer.<SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&ldquo;The
refreshed Board and the new CEO of Gildan have the right business plan, clear commitments to keeping its headquarters in Qu&eacute;bec
and to pay Global Minimum Tax. This is why CDPQ has decided to support the growth of this major Qu&eacute;bec company. It&rsquo;s a first
step to a partnership that will expand with our intention to become an important shareholder of the company in this new context,&rdquo;
said Kim Thomassin, Executive Vice-President and Head of Qu&eacute;bec at CDPQ.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&ldquo;We
are pleased that given our longstanding relationship, CDPQ, one of Canada&rsquo;s most admired and successful investors, has decided
to make this investment in Gildan. We view it as a strong validation of our Board, management team and ongoing commitment to shareholder
value creation,&rdquo; said Tim Hodgson, Chairman of Gildan Activewear.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&ldquo;We
believe this investment and partnership with CDPQ is a very positive indicator about the strength and potential of the business as well
as the refreshed Board and management team. I look forward to leading Gildan from my new home city of Montr&eacute;al and creating value
for all of Gildan&rsquo;s shareholders,&rdquo; said Vince Tyra, CEO of Gildan Activewear.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Closing
of the transaction is expected to occur on or around June 4, 2024, and will be contingent on successful completion of confirmatory due
diligence and other customary closing requirements.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
notes are being offered in Canada on a private placement basis in reliance upon exemptions from the prospectus requirements under applicable
securities legislation. The notes have not been and will not be</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><SUP>1
</SUP>See the Company&rsquo;s prior disclosure in respect of Global Minimum Tax, including the Company&rsquo;s May 1, 2024 press release
under the heading &ldquo;2024 Outlook&rdquo;, accessible at the following link: <FONT STYLE="color: blue"><U>Gildan Activewear Reports
Results for the First Quarter of 2024</U></FONT>.</FONT></P>
<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 45%"></TD><TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></TD><TD STYLE="width: 45%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">qualified
for sale to the public under applicable securities laws in Canada and, accordingly, any offer and sale of the notes in Canada will be
made on a basis which is exempt from the prospectus requirements of such securities laws. The notes have not been and will not be registered
under the United States Securities Act of 1933, as amended (the &ldquo;U.S. Securities Act&rdquo;), or the securities laws of any other
jurisdiction, and may not be offered or sold in the United States absent registration under, or an applicable exemption from the registration
requirements of, the U.S. Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to
buy, nor shall there be any offer to sell or a solicitation of an offer to buy the notes in any jurisdiction where it is unlawful to
do so.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Caution
Concerning Forward-Looking Statements</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Certain
statements included in this press release constitute &ldquo;forward-looking statements&rdquo; within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 and Canadian securities legislation and regulations and are subject to important risks, uncertainties,
and assumptions. This forward-looking information includes, amongst others, information with respect to the final terms of the notes,
the expected use of proceeds from the transaction, the completion of the transaction and the timing for its completion, the satisfaction
of closing conditions to the transaction, Gildan&rsquo;s intention to maintain its global headquarters in Qu&eacute;bec, Gildan paying
the Global Minimum Tax, CDPQ&rsquo;s intention to become a shareholder of Gildan and Gildan&rsquo;s objectives and strategies to achieve
these objectives. Forward-looking statements generally can be identified by the use of conditional or forward-looking terminology such
as &ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;expect&rdquo;, &ldquo;intend&rdquo;, &ldquo;estimate&rdquo;, &ldquo;project&rdquo;,
&ldquo;assume&rdquo;, &ldquo;anticipate&rdquo;, &ldquo;plan&rdquo;, &ldquo;foresee&rdquo;, &ldquo;believe&rdquo;, or &ldquo;continue&rdquo;,
or the negatives of these terms or variations of them or similar terminology. Forward- looking information involves known and unknown
risks and uncertainties, many of which are beyond our control, that could cause actual results to differ materially from those that are
disclosed in or implied by such forward-looking information. These risks and uncertainties include, but are not limited to, the risk
that the transaction may not be completed and any restrictions imposed by applicable securities laws. We refer you to the Company&rsquo;s
&filig;lings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, as well as the risks
described under the &ldquo;Financial risk management&rdquo;, &ldquo;Critical accounting estimates and judgments&rdquo;, and &ldquo;Risks
and uncertainties&rdquo; sections of our most recent Management&rsquo;s Discussion and Analysis for a discussion of the various factors
that may a&fflig;ect these forward-looking statements. Material factors and assumptions that were applied in drawing a conclusion or
making a forecast or projection are also set out throughout such document.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Forward-looking
information is inherently uncertain and the results or events predicted in such forward- looking information may differ materially from
actual results or events. Material factors, which could cause actual results or events to differ materially from a conclusion or projection
in such forward-looking information, include, but are not limited to changes in general economic, financial or geopolitical conditions
globally or in one or more of the markets we serve, including the pricing and inflationary environment, and our ability to implement
our growth strategies and plans, as well as those factors listed in our most recent Management&rsquo;s Discussion and Analysis under
the &ldquo;Risks and uncertainties&rdquo; and &ldquo;Caution regarding forward-looking statements&rdquo; sections. These factors may
cause the Company&rsquo;s actual performance in future periods to differ materially from any estimates or projections of future performance
expressed or implied by such forward-looking information.</FONT></P>
<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 45%"></TD><TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD><TD STYLE="width: 45%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">There
can be no assurance that the expectations represented by our forward-looking statements will prove to be correct. The purpose of the
forward-looking statements is to provide the reader with a description of management&rsquo;s expectations regarding the Company&rsquo;s
future financial performance and may not be appropriate for other purposes. Furthermore, unless otherwise stated, the forward-looking
statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update publicly
or to revise any of the included forward-looking statements, whether as a result of new information, future events, or otherwise unless
required by applicable legislation or regulation. The forward-looking statements contained in this press release are expressly qualified
by this cautionary statement.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">About
Gildan</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Gildan
is a leading manufacturer of everyday basic apparel. The Company&rsquo;s product offering includes activewear, underwear and socks, sold
to a broad range of customers, including wholesale distributors, screenprinters or embellishers, as well as to retailers that sell to
consumers through their physical stores and/or e-commerce platforms and to global lifestyle brand companies. The Company markets its
products in North America, Europe, Asia Pacific, and Latin America, under a diversified portfolio of Company-owned brands including Gildan&reg;,
American Apparel&reg;, Comfort Colors&reg;, GOLDTOE&reg; and Peds&reg;.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Gildan
owns and operates vertically integrated, large-scale manufacturing facilities which are primarily located in Central America, the Caribbean,
North America, and Bangladesh. Gildan operates with a strong commitment to industry-leading labour, environmental and governance practices
throughout its supply chain in accordance with its comprehensive ESG program embedded in the Company's long-term business strategy. More
information about the Company and its ESG practices and initiatives can be found at <FONT STYLE="color: blue"><U>www.gildancorp.com</U></FONT>.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">About
CDPQ</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">At
CDPQ, we invest constructively to generate sustainable returns over the long term. As a global investment group managing funds for public
pension and insurance plans, we work alongside our partners to build enterprises that drive performance and progress. We are active in
the major financial markets, private equity, infrastructure, real estate and private debt. As at December 31, 2023, CDPQ&rsquo;s net
assets totalled CAD 434 billion. For more information, visit cdpq.com, consult our LinkedIn or Instagram pages, or follow us on X.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>CDPQ
is a registered trademark owned by Caisse de d&eacute;p&ocirc;t et placement du Qu&eacute;bec and licensed for use by its subsidiaries.</I></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Media
    relations team - Gildan</B></FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">+1
    514 343-8814</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><U>communications@gildan.com</U></FONT></P></TD>
    <TD STYLE="width: 51%"><P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Media
    relations team &ndash; CDPQ:</B></FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">+
    1 514 847-5493</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: blue"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><U>medias@cdpq.com</U></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 45%"></TD><TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD><TD STYLE="width: 45%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #__@ 23$5!1%1/3TQ3('8R,BXP /_; (0
M!04%" 4(# <'# P)"0D,#0P,# P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0$%" @*!PH,!P<,#0P*# T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-_\0!H@
M 04! 0$! 0$           $" P0%!@<("0H+ 0 # 0$! 0$! 0$!
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M\O/T]?;W^/GZ_\  $0@ , +3 P$1  (1 0,1 ?_:  P# 0 "$0,1 #\ ^RZ
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M[Z2C^S*O\T?Q#^T:?\LOP#_AH/2O^?6X_P"^DH_LRK_-'\0_M&G_ "R_ /\
MAH/2O^?6X_[Z2C^S*O\ -'\0_M&G_++\ _X:#TK_ )];C_OI*/[,J_S1_$/[
M1I_RR_ /^&@]*_Y];C_OI*/[,J_S1_$/[1I_RR_ /^&@]*_Y];C_ +Z2C^S*
MO\T?Q#^T:?\ ++\ _P"&@]*_Y];C_OI*/[,J_P T?Q#^T:?\LOP#_AH/2O\
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MX?X(_DCX6K_$G_BE^9BUN8A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M_)'PM7^)/_$_S,6MS$* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#W0^.H?#>B:(]G
M%;W5];PW@#N6+VK/(!D*"!EU8\-GA?K7S_U9UZU;G<HP<H:+:6C_ "_4]KZP
MJ-*CRI2DE+_MW;\_T-CPGXPTW2]&T=+X0SR_VA.92_,EMYDDA6X4=L,P))_A
MS6%?#SJ5JW)=+DC;M*RC[OW7-J-:$*5+GLWSN_>-V]2'0KFWM[+6+&66QOIY
MM265/MCXBG4Y8S9 ZG.[V;(JJJDY49I3A%4VO=6L7M;\":<E&-6#<9-U+KF>
MC\S*\)WLUG?:A:J=+^RSR1>?9/)MMG3!.Z!R,?N\X([L1Z5K7BI0IRM4YDI6
MDE[R=]I+S,Z,G&4XWARMJ\;Z-=UZ&EI%U:Z?J^IV>BRV4^DS20A[:]<JDBA,
MNT3GM$^Y5'<;.P%95(RE2I3K*:J)2M**U6NEUY[FD)1A4J0I.+IMJ\9/?O9^
M6QY/XSBTZWUNX31VWV2R+Y;9)'W5+A2>2JON5?\ 9 [5Z]#GE1C[56G9W_&W
MSM8\RNH1JR]G\-U;]?QN>Y^*_%.FZQ-KFG6CV]O/-:PM%>)UNU2.(R6[L>,G
M_5IC' (/2O"HT9TU1J34G%2=X?RW;]Y?F>S5JPFZM.+2;BFI?S66L2;4M4LM
M1T/1X(!I=[);6<2RI?2;3$WD0+A, \DJP?\ W5I1A*-:M*7M(IS=G!;^]+?[
MU8)3C*E24>1M15^9[>ZOU//S91ZWX5M=-AN;2&XMK^YD=)9=@"-N4%3@Y!/3
MVYKO4G2Q$JKC-Q=.*32OKIN<3BJE"--2BI*<FTW;34V_#\EO;>&_[*?^S+NY
M@U*9FCNY/W6P1!?-C('S$GA3@94M6%9.5?VJ52,736L5K>][,VIM1H^SO!R4
MWI)Z>J*/A^_TSPUI^J7%W.MO=:E<M:QK8XD,$*EI&:+.,1,28U/HJ&M*L*E>
M=*$(MQA%2?/I=O37SZLBG*%&%1RDE*4N5<NMDNWD:%]JT,GB*#Q#H-W;POJ%
MJ?-2X^56E3;')%*!D)YJA7!Z;E)]*SC!^PEAZ\)-0FK./1.[37>S;+<U[:->
MC**YHZIZ:JRL_4VK"\T32?%>G7B/;6LC6MP;U()-UM%*8R$V-TR^3G'MGDUE
M*-6>'J0:E)<T>1M>\U?6_H:J5.%>G)-)\LN:S]U.VAY+XZ11Y#+#IL S+_R#
MW+%L["#+P,8Q\G^\U>KA?M*]1[?&K6WV^_4\S$=+*"W^%_F>?5ZAP'W)\%_^
M14L_]ZY_]*9:^'Q_^\3_ .W?_2(GU^"_@1^?_I3-KXFZ7+K7A;5+*W!::2RF
M**!DLR*9 @&1RY78/0D&O,/1/B/P;X[M=4T_2]+OYH;'5?#=V+G2;NZR+.:(
MNK265W(H+6X?:NRXVE J*&:,J'8 I?$;P1?:GJ]QX@),-IJ$WVB4W<D:FW$C
MHKK'.SK:WL,3/M@:RN)LQ*@98R"H .J\+IX&^%-ZNM0ZI)XGU:)66RM;2V>&
M,22J8MS.6E0MAF49D+*'W+ [A" #1U;2;KPY\,[V'Q"OV?4_$&J)=V5DR_O8
MW:6V9]L1S*CF))=RDDHLD<;A9)&! /LKPMI;:'H]CIK_ 'K*SMK=LX)S#"D9
MY''5>W'I0!\0Z9JD?PZ^+-W/K.(+>YO;S=*>%CBOR\L$I)P @,D8E;[J+YAY
MVT ?>9O(%A^U&2,0;0_FEU$>P@$-OSMVD$$-G!!'- 'Q%^UE_P A73/^O27_
M -&B@#[3U'5K/1+4WFHS1VMO$N6DE<(HXSC+$9)P<*,D] ": /B#X.1OXT^)
M=WXDM49;2"6^O,[0H"W(F@@1^PD=9BY Y8HYZ T <1X"\+ZOXM\6:E9Z#J$F
MCW,8NYGGCDFC9HENXD:(M RN0SNCX)VY0$C(% 'T[X ^ 2>'=5'B/Q!?/K&I
M(QD0L'V++T$TDDCO)/(!RA;:$;G#%58 'B6E7*>!OC!/)JC+!!<7UXQED 55
M2_266!MQ("C?-&K2$X"[\XY  /L#XD^(+;PSX;U"^NF5?]%FCB5CCS)I8V2*
M)1U)=R,X!(4,Q&%)H ^??V3-*F@L=5U)QB&ZFMH(SZM;),\A'J/])09Z9!'4
M' !]=4 <EXO\(6OB^U%M<DHT3;XG7JC$$=#P00>177AZ\L+/VD-;JS3ZHXL3
MAXXJ'LY-KJFNC/E_Q/\ #_4_#!+RIYUN#Q-&"5Q_M#JOXU]GA\;2Q&B?++^5
M_IW/BL1@JN&U:YH?S+]5T/1?$7A2_P#$>M$6J8B$-N&E;A%_<IW[GV%>?A\5
M3PV'7._>YIVBM_B?W';B<)5Q6)?LU:/+"\GLO=7WGJ/@_P $6OA-7DC/F7$X
M422$8R%R0%'89)]SQFO!Q6*EBVKI*,;V2\^Y]%A,''!Q:3;;M=OR[>1>\7^%
M+;QAI[Z?=97)#QR+]Z.1<X8?@2".X)%84*TL--5(>C7==CKK4HUX\DOD^S/&
M[7X:>+](06VGZML@3A%!< #L,'./PX]*]=XO#3]ZI2][KL>6L-7A[L*FG0L^
M'/A7JVFMJDU[<133:K8W5OOYSYUP0Q=_8G)./6IJXRG-4HPBTJ<XR^4;Z%4\
M).'M')IN<)1^;ZEZ/X22W'A=-!NID6Z@N7N(I5!* L"-K#K@J3G'< ]JAXU1
MQ#Q$%[KBHM/?^KEK"-T51D_>4G)-&9#X"\<6R+%%J^U$ 50&;@#@#D>E:/$X
M1ZNEJ_0S5#$I65076OAAX@OM1@U>VO$BNX;6WB:8D[S-' (Y7!_VSN/T-%/&
M484Y490;@YR:7DW=(*F%JRG&K&24E&*OYI6;^9'=?#3Q=K"?9M2U;?;M]]26
M.1W&!C/X\>M$<7AJ7O4Z7O=!/#5Y^[.IIU+VJ?!Z2X;3K"VD1=+L#NF#9\R:
M220-.YQQED547^Z!CI40QW+[6I)/VL]K;123Y5^-S26#O[.$6O9QW75MM7?X
M'NBV-NH $<8 &/N+_A7BW?=GK<J[+[CR27X=WMEXDGUK39(H[6]B>.>$@@_O
M(]K8QQ_K LH]\BO4^M1E0C0J)N4'>+]'I^%T>=]7E&LZT&E&2LUZK_-7-[X8
M^$+GP7IDEA=NDCR7+S IG&UHH4 Y[YC/YBL,776)J*I%-)12U]7_ )FN%HO#
MP<)--WOIZ+_(XGXA?!Y_$FH'4M,DC@:8?OT<'!<<!UQW8?>'<C/<UVX7'>PA
M[*HFTOA:[=CDQ&"]K/VE-I-[_P"9[M:QF&%(SU1%4_4 "O$;NV_-GL)621.:
M0S\XO$O_ "%KW_K[N/\ T<]?HE'^'#_!'\D?"U?XD_\ %+\V8M;F(4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MC$R!W#!V .EH * &21K*I1P&5A@@C((]"#P:>VJ$U?1["JH48'&*0]AU !0
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M>P]E#^6/W(/^$7TK_GTM_P#OTG^%'M9_S2^]A[*'\L?N0?\ "+Z5_P ^EO\
M]^D_PH]K/^:7WL/90_EC]R#_ (1?2O\ GTM_^_2?X4>UG_-+[V'LH?RQ^Y!_
MPB^E?\^EO_WZ3_"CVL_YI?>P]E#^6/W(/^$7TK_GTM_^_2?X4>UG_-+[V'LH
M?RQ^Y!_PB^E?\^EO_P!^D_PH]K/^:7WL/90_EC]R#_A%]*_Y]+?_ +])_A1[
M6?\ -+[V'LH?RQ^Y!_PB^E?\^EO_ -^D_P */:S_ )I?>P]E#^6/W(/^$7TK
M_GTM_P#OTG^%'M9_S2^]A[*'\L?N0?\ "+Z5_P ^EO\ ]^D_PH]K/^:7WL/9
M0_EC]R#_ (1?2O\ GTM_^_2?X4>UG_-+[V'LH?RQ^Y!_PB^E?\^EO_WZ3_"C
MVL_YI?>P]E#^6/W(UK6TAL8Q#;HL4:YPB *HR<G '')))]ZR;<G>3N^[-4E%
M6BK+LBQ2&% 'F^M?"'PAX@<RWNEVQD8Y9H0]LS'GEFMGA+$Y.222W&<X& "Q
MH'PK\*^&)%FTW3;:*:,Y25PT\J').5DG:5U/) *L"!\H.WB@#T"@ H * "@
2H * "@ H * "@ H * "@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
